iQure Pharma

Princeton, NJ · Founded 2019 · Privately Held (backing)

Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. iQure Pharma is based in Princeton, NJ and was founded in 2019. Its last reported valuation was $21 million in Nov 2025. It has raised $13.1 million across 4 recorded rounds; the latest was a $650,000 seed round in May 2026.

Last reported valuation
$21.0M
Oct 2026
Priced at
—
Total raised
$13.1M
Last round
Seed Round
May 2026
What is iQure Pharma worth?
$21.0Mlast reported valuation · Oct 2026

iQure Pharma's last reported valuation, Nov 2025. Nothing priced has surfaced since.

Free account
More of iQure Pharma with a free account
  • ·Watch iQure Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

iQure Pharma funding history

4 rounds
DateRoundRaisedPost-money
May 2026Seed Round$650K▮
Sep 2025Seed Round$1.5M▮
Dec 2024Debt$1.4M▮
Oct 2023Seed Round$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

iQure Pharma valuation

iQure Pharma's last reported valuation was $21 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has iQure Pharma raised?

iQure Pharma has raised $13.1 million in total; 4 of its rounds are on record, from 2023 on. The largest on record was a $650,000 seed round in May 2026.

iQure Pharma has filed 3 Form Ds with the SEC since 2023, most recently in Jan 2025 ($1.4 million sold to 2 investors).

How iQure Pharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For iQure Pharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about iQure Pharma

What is iQure Pharma worth?
iQure Pharma is valued at $21.0M as of Oct 2026. iQure Pharma's last reported valuation, Nov 2025. Nothing priced has surfaced since.
How much has iQure Pharma raised?
iQure Pharma has raised $13.1M in total funding across 4 recorded rounds.
When did iQure Pharma last raise?
iQure Pharma last raised in May 2026 (Seed Round), raising $650K.